American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause

AACE Menopause Guidelines Revision Task Force


Endocr Pract. 2006;12(3):315-337. 

In This Article

Contraindications to HT

The FDA has recommended that HT should generally not be prescribed to women with the following conditions:

  1. Current, past, or suspected breast cancer

  2. Known or suspected estrogen-sensitive malignant conditions

  3. Undiagnosed genital bleeding

  4. Untreated endometrial hyperplasia

  5. Previous idiopathic or current venous thromboembolism (deep vein thrombosis, pulmonary embolism)

  6. Active or recent arterial thromboembolic disease (angina, MI)

  7. Untreated hypertension

  8. Active liver disease

  9. Known hypersensitivity to the active substances of HT or to any of the excipients

  10. Porphyria cutanea tarda (absolute contraindication)


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: